GeneDx Partners with Epic Aura to Enhance Rapid Whole Genome Sequencing Services for Pediatric and Neonatal Patients
GeneDx, a leading provider of genetic testing services, has announced a collaboration with Epic Aura to expand access to rapid Whole Genome Sequencing (rWGS) services for pediatric and neonatal patients. This partnership aims to streamline access for health systems and improve the provider and patient journeys by utilizing Epic for electronic connections.
By joining forces with Epic Aura, GeneDx looks to increase its commercial footprint and focus on accelerating the utilization of rWGS services in neonatal intensive care units (NICUs). This strategic alliance will enable health systems to leverage the power of rWGS technology to inform diagnosis and improve patient outcomes in affected pediatric and neonatal patients.
With the integration of Epic Aura’s platform, health systems can now seamlessly access GeneDx’s rWGS services, enhancing the efficiency and effectiveness of diagnostic testing for a range of genetic disorders. This collaboration represents a significant step forward in advancing precision medicine and personalized care for pediatric and neonatal patients.
In conclusion, the partnership between GeneDx and Epic Aura marks a significant advancement in the field of genetic testing and personalized medicine. By expanding access to rWGS services for pediatric and neonatal patients, this collaboration promises to revolutionize the way healthcare providers diagnose and treat genetic disorders in these vulnerable populations.
Comments